Medical Company Receives New Patent For COVID-19 Drug
RedHill Biopharma's New Patent: A Potential Game-Changer in the Fight Against Coronavirus.
In a significant development in the medical community, RedHill Biopharma Ltd ($RDHL) has been granted US patent number 11,918,560, titled "Serine Protease Inhibitor for Treating Coronavirus Infection". The implications of this breakthrough could be far-reaching, potentially reshaping our approach to managing and treating coronavirus infections. $Redhill Biopharma(RDHL.US$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
